Prelude Therapeutics
PRLD
#9186
Rank
S$96.94 M
Marketcap
$1.76
Share price
46.40%
Change (1 day)
-68.42%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -$2.92

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.94. In 2022 the company made an earnings per share (EPS) of -$3.31 a decrease over its 2021 EPS that were of -$3.28.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.92-11.63%
2022-$3.310.83%
2021-$3.28-61.3%
2020-$8.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.95 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA